Cargando…

Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?

We have read the article “Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonnalagadda, Venu Gopal, Choudhary, Kanchan, Matety, Vijay Kranti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719742/
https://www.ncbi.nlm.nih.gov/pubmed/29234523
http://dx.doi.org/10.1186/s40885-017-0082-0
_version_ 1783284547090120704
author Jonnalagadda, Venu Gopal
Choudhary, Kanchan
Matety, Vijay Kranti
author_facet Jonnalagadda, Venu Gopal
Choudhary, Kanchan
Matety, Vijay Kranti
author_sort Jonnalagadda, Venu Gopal
collection PubMed
description We have read the article “Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active controlled, phase 4, randomized trial” by GC Oh., et al. and found it quite interesting to learn the testing of effectiveness between amlodipine and hydrochlorothiazide in combination with losartan. After 4 weeks of therapy, non-responders were exposed for dose titration of losartan/amlodipine 100/5 mg daily or losartan/hydrochlorothiazide 100/25 mg daily. However, authors didn’t increase in the amlodipine dose from 5 to 10 mg from randomization. However, as per literature both drugs are non-significant in their blood pressure lowering effect. The clarification on above point will further allay the efficacy concerns of clinicians and result in wider usage of future published data.
format Online
Article
Text
id pubmed-5719742
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57197422017-12-11 Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not? Jonnalagadda, Venu Gopal Choudhary, Kanchan Matety, Vijay Kranti Clin Hypertens Letter to the Editor We have read the article “Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active controlled, phase 4, randomized trial” by GC Oh., et al. and found it quite interesting to learn the testing of effectiveness between amlodipine and hydrochlorothiazide in combination with losartan. After 4 weeks of therapy, non-responders were exposed for dose titration of losartan/amlodipine 100/5 mg daily or losartan/hydrochlorothiazide 100/25 mg daily. However, authors didn’t increase in the amlodipine dose from 5 to 10 mg from randomization. However, as per literature both drugs are non-significant in their blood pressure lowering effect. The clarification on above point will further allay the efficacy concerns of clinicians and result in wider usage of future published data. BioMed Central 2017-12-06 /pmc/articles/PMC5719742/ /pubmed/29234523 http://dx.doi.org/10.1186/s40885-017-0082-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter to the Editor
Jonnalagadda, Venu Gopal
Choudhary, Kanchan
Matety, Vijay Kranti
Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
title Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
title_full Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
title_fullStr Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
title_full_unstemmed Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
title_short Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
title_sort amlodipine vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719742/
https://www.ncbi.nlm.nih.gov/pubmed/29234523
http://dx.doi.org/10.1186/s40885-017-0082-0
work_keys_str_mv AT jonnalagaddavenugopal amlodipinevshydrochlorothiazideisthereanydisparityinitsantihypertensiveeffectornot
AT choudharykanchan amlodipinevshydrochlorothiazideisthereanydisparityinitsantihypertensiveeffectornot
AT matetyvijaykranti amlodipinevshydrochlorothiazideisthereanydisparityinitsantihypertensiveeffectornot